0001562180-21-007298.txt : 20211126 0001562180-21-007298.hdr.sgml : 20211126 20211126162646 ACCESSION NUMBER: 0001562180-21-007298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211123 FILED AS OF DATE: 20211126 DATE AS OF CHANGE: 20211126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark George C. CENTRAL INDEX KEY: 0001878290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 211452031 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-11-23 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001878290 Clark George C. C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false VP, Chief Accounting Officer Common Shares 2021-11-23 4 M false 1915.00 32.42 A 7473.00 D Common Shares 2021-11-26 4 M false 5000.00 0.00 A 12473.00 D Common Shares 2021-11-26 4 F false 2318.00 115.55 D 10155.00 D Employee Stock Option (right to buy) 32.42 2021-11-23 4 M false 1915.00 0.00 D 2028-11-20 Common Shares 1915.00 4795.00 D Restricted Share Unit Award 2021-11-26 4 M false 5000.00 0.00 D Common Shares 5000.00 15000.00 D No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date. Each restricted share unit represents the contingent right to receive one common share of the issuer. The reporting person was granted 20,000 restricted share units on May 7, 2021, vesting in four equal installments on May 7, 2021, 2022, 2023 and 2024 subject to the reporting person's continued service with the issuer at each vesting date. Not applicable. /s/ George C. Clark 2021-11-26